Actavis plc agreed to pay about $66bn (€53bn) for Allergan, a deal that creates a new top 10 drugmaker and ends Valeant Pharmaceuticals International’s attempt at a hostile takeover of the maker of Botox.

WELL, that’s easy for Tom Waits or Bruce Springsteen to say.